RE:New tweet The results do look impressive. Now SBM via CURE need to get the word out to investors. The more potent formulation that recently wrapped its clinical trial should produce even more dramatic results and garner more attention. Wonder if R&F's have already inquired about adding it to their lineup?
Once word gets out there should be a line up of companies wanting SBM's compound to replace their old cancer causing compound that had mostly been banned around the globe.